Which investigations should be ordered for a patient with suspected gouty arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Studies for Suspected Gouty Arthritis

Joint Aspiration with Synovial Fluid Analysis (Gold Standard)

Joint aspiration with polarized light microscopy to identify needle-shaped, negatively birefringent monosodium urate (MSU) crystals is the definitive diagnostic test and should be performed whenever feasible, particularly for first attacks, atypical presentations, or when septic arthritis cannot be excluded. 1

  • Synovial fluid analysis has sensitivity and specificity approaching 100% when performed by experienced operators 1
  • MSU crystals appear as needle-shaped, negatively birefringent crystals under polarizing microscopy 1
  • Gram stain and culture must be performed on all aspirated fluid even when MSU crystals are identified, because gout and septic arthritis can coexist 1
  • Joint aspiration is technically difficult and painful in smaller joints, which limits routine use in primary care settings 2

Serum Uric Acid Level

  • Measure serum uric acid, but recognize its significant limitations: hyperuricemia alone cannot diagnose gout, and normal levels do not exclude it 1
  • Approximately 10% of patients with acute gout have normal serum uric acid levels during an attack because uric acid behaves as a negative acute phase reactant during inflammation 1
  • Only 22% of asymptomatic patients with serum uric acid levels above 9 mg/dL develop gout over 5 years 1
  • Serum uric acid has 53-61% specificity for gout diagnosis but is essential for long-term management decisions 1

Imaging Studies

First-Line: Ultrasound

  • Ultrasound should be the initial advanced imaging modality when joint aspiration is not feasible or when clinical diagnosis is uncertain 1
  • The "double contour sign" on ultrasound has 74% sensitivity and 88% specificity for detecting MSU crystal deposition 1
  • Ultrasound detects tophi with 65% sensitivity and 80% specificity 1
  • Always include the first metatarsophalangeal joint in imaging, even if asymptomatic, as this is the disease-specific target site 1
  • Ultrasound performs better in late disease (>2 years duration) with 63% sensitivity compared to 50% in early disease (<2 years) 1

Second-Line: Dual-Energy CT (DECT)

  • DECT should be considered when ultrasound is negative but clinical suspicion remains high, particularly in patients with disease duration >2 years 1
  • DECT has 85-100% sensitivity and 83-92% specificity for detecting MSU crystal deposition 1
  • DECT is less sensitive in early disease and involves radiation exposure and higher cost 1

Limited Role: Plain Radiography

  • Plain radiographs are useful only for assessing chronic structural damage or excluding alternative diagnoses 1
  • Radiography should not be the primary diagnostic imaging modality for acute gout 1
  • Radiographs are frequently normal in early or acute gout, showing at most nonspecific soft-tissue swelling 1

Inflammatory Markers

  • Check ESR and CRP to assess inflammation severity and help rule out infection 1
  • Complete blood count should be obtained to evaluate for infection 1

Renal Function Assessment

  • Measure serum creatinine and calculate eGFR to assess kidney function 1
  • Chronic kidney disease increases gout risk 4.95-fold and influences treatment decisions 1

24-Hour Urinary Uric Acid Excretion (Selected Patients Only)

  • Obtain 24-hour urinary uric acid in patients with family history of young-onset gout, onset under age 25, or history of renal calculi 1
  • This test identifies urate overproducers versus underexcretors, which influences choice of urate-lowering therapy 1

Risk Factor and Comorbidity Screening

  • Systematically screen for modifiable risk factors: chronic kidney disease (RR 4.95), obesity (RR 3.81), hypertension (RR 3.93), and diuretic use (RR 1.72) 1
  • Evaluate medications including diuretics, low-dose aspirin, cyclosporine, and tacrolimus 1
  • Screen for associated comorbidities: renal impairment, ischemic heart disease, heart failure, diabetes mellitus, and dyslipidemia 1
  • Assess alcohol consumption and dietary factors (meat, shellfish, high-fructose corn syrup) 1

Clinical Diagnostic Algorithm When Aspiration Not Feasible

  • Clinical algorithms demonstrate sensitivities and specificities >80% for diagnosing early-onset gout, particularly in patients with recent-onset attacks 2
  • Key clinical features include: maximum inflammation developing within 24 hours, erythema over the affected joint, first metatarsophalangeal joint involvement (podagra), and history of previous similar attacks 1
  • However, the relatively low specificity of clinical algorithms raises risk for missed diagnosis of septic arthritis—if infection cannot be excluded clinically, joint aspiration with Gram stain and culture is mandatory 2

Common Pitfalls to Avoid

  • Do not diagnose gout based on hyperuricemia alone—up to 80% of patients with hyperuricemia never develop gout 1
  • Do not exclude gout based on normal serum uric acid during an acute attack 1
  • Septic arthritis cannot be excluded based solely on clinical appearance; when in doubt, aspirate 1
  • Do not rely on imaging alone—integrate patient history, physical examination, and laboratory findings into the diagnostic assessment 1

References

Guideline

Diagnosis of Gout

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.